BiotechTube

Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine

Phase 1Active
2 views this week 0 watching💤 Quiet
Interest: 33/100
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pediatric Solid Tumor

Conditions

Pediatric Solid Tumor

Trial Timeline

Oct 25, 2022 → Jun 1, 2025

NCT ID
NCT05620862

About Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine

Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine is a phase 1 stage product being developed by Sun Pharmaceutical for Pediatric Solid Tumor. The current trial status is active. This product is registered under clinical trial identifier NCT05620862. Target conditions include Pediatric Solid Tumor.

What happened to similar drugs?

3 of 19 similar drugs in Pediatric Solid Tumor were approved

Approved (3) Terminated (0) Active (16)
✅Boosted AtazanavirBristol Myers SquibbApproved
✅Atazanavir + RitonavirBristol Myers SquibbApproved
✅IgPro10CSLApproved
🔄candsartan cilexetilAstraZenecaPhase 3
🔄basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroidsNovartisPhase 3
🔄VAL489 + VAL489 matching placeboNovartisPhase 3
🔄Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3

Hype Score Breakdown

Clinical
6
Activity
12
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05620862Phase 1Active

Competing Products

20 competing products in Pediatric Solid Tumor

See all competitors
ProductCompanyStageHype Score
RamucirumabEli LillyPhase 1
29
erlotinib + etoposideAstellas PharmaPhase 2
27
Perampanel Oral Suspension + Perampanel TabletEisaiPhase 2
42
Eribulin MesylateEisaiPhase 1
29
Decitabine + DecitabineEisaiPhase 2
27
Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once dailySumitomo PharmaPhase 1
29
Remimazolam Tosilate for injection + Propofol InjectionJiangsu Hengrui MedicinePhase 2/3
45
Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or LinezolidAstraZenecaPhase 2/3
38
candsartan cilexetilAstraZenecaPhase 3
40
Durvalumab / Tremelimumab Combination TherapyAstraZenecaPhase 1/2
36
Rotavirus VaccineMerckPre-clinical
18
basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroidsNovartisPhase 3
40
VAL489 + VAL489 matching placeboNovartisPhase 3
40
LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696NovartisPhase 2/3
38
EverolimusNovartisPhase 2
35
Corticosteroids + Cyclosporine + mycophenolate mofetilRochePhase 2
27
Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3
40
Blinatumomab for InjectionAmgenPhase 1
25
EtanerceptAmgenPhase 3
40
DenosumabAmgenPhase 3
40